Key Financial Data Of Reporting Company

JCR Pharmaceuticals Co.,Ltd. - Filing #7724991

Concept As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
20,304,000,000 JPY
20,594,000,000 JPY
17,794,000,000 JPY
18,085,000,000 JPY
17,128,000,000 JPY
17,438,000,000 JPY
16,539,000,000 JPY
16,855,000,000 JPY
15,426,000,000 JPY
15,705,000,000 JPY
Ordinary profit (loss)
3,794,000,000 JPY
3,843,000,000 JPY
2,442,000,000 JPY
2,534,000,000 JPY
2,347,000,000 JPY
2,443,000,000 JPY
2,250,000,000 JPY
2,340,000,000 JPY
1,635,000,000 JPY
1,680,000,000 JPY
Profit (loss)
3,015,000,000 JPY
1,870,000,000 JPY
1,736,000,000 JPY
1,646,000,000 JPY
1,179,000,000 JPY
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
9,061,000,000 JPY
9,061,000,000 JPY
9,061,000,000 JPY
Total number of issued shares
32,421,000 xbrli:shares
32,421,000 xbrli:shares
32,421,000 xbrli:shares
32,421,000 xbrli:shares
32,421,000 xbrli:shares
Net assets
27,049,000,000 JPY
27,528,000,000 JPY
27,585,000,000 JPY
27,399,000,000 JPY
26,855,000,000 JPY
27,062,000,000 JPY
26,034,000,000 JPY
26,264,000,000 JPY
24,580,000,000 JPY
24,466,000,000 JPY
Total assets
37,756,000,000 JPY
38,398,000,000 JPY
36,385,000,000 JPY
35,977,000,000 JPY
34,924,000,000 JPY
35,346,000,000 JPY
33,690,000,000 JPY
34,086,000,000 JPY
33,464,000,000 JPY
33,047,000,000 JPY
Net assets per share
868.29
877.86
864.66
858.80
836.87
843.34
811.44
818.64
768.13
764.56
Dividend paid per share
26.00
22.00
22.00
18.50
17.00
Interim dividend paid per share
12.00
10.00
10.00
8.50
7.00
Basic earnings (loss) per share
96.97
98.73
59.19
58.95
54.46
56.12
51.72
52.85
37.13
40.79
Diluted earnings per share
96.36
98.11
58.84
58.61
54.15
55.81
51.41
52.53
36.89
40.52
Equity-to-asset ratio
0.707 xbrli:pure
0.703 xbrli:pure
0.750 xbrli:pure
0.754 xbrli:pure
0.762 xbrli:pure
0.759 xbrli:pure
0.768 xbrli:pure
0.766 xbrli:pure
0.730 xbrli:pure
0.735 xbrli:pure
Rate of return on equity
0.112 xbrli:pure
0.113 xbrli:pure
0.070 xbrli:pure
0.069 xbrli:pure
0.066 xbrli:pure
0.068 xbrli:pure
0.065 xbrli:pure
0.066 xbrli:pure
0.050 xbrli:pure
0.054 xbrli:pure
Price-earnings ratio
62.6 xbrli:pure
61.5 xbrli:pure
41.7 xbrli:pure
41.9 xbrli:pure
47.0 xbrli:pure
45.7 xbrli:pure
48.6 xbrli:pure
47.6 xbrli:pure
63.8 xbrli:pure
58.1 xbrli:pure
Payout ratio
0.268 xbrli:pure
0.372 xbrli:pure
0.404 xbrli:pure
0.358 xbrli:pure
0.458 xbrli:pure
Net cash provided by (used in) operating activities
3,133,000,000 JPY
2,651,000,000 JPY
2,201,000,000 JPY
499,000,000 JPY
4,565,000,000 JPY
Net cash provided by (used in) investing activities
-1,587,000,000 JPY
-841,000,000 JPY
-980,000,000 JPY
-1,419,000,000 JPY
-2,668,000,000 JPY
Net cash provided by (used in) financing activities
-2,175,000,000 JPY
146,000,000 JPY
-1,314,000,000 JPY
-1,261,000,000 JPY
-369,000,000 JPY
Cash and cash equivalents
4,850,000,000 JPY
5,464,000,000 JPY
3,523,000,000 JPY
3,643,000,000 JPY
5,780,000,000 JPY
Number of employees
540 xbrli:pure
568 xbrli:pure
566 xbrli:pure
522 xbrli:pure
482 xbrli:pure
526 xbrli:pure
458 xbrli:pure
501 xbrli:pure
472 xbrli:pure
430 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.